한글목차

유방 재건 세계 시장은 2030년까지 10억 달러에 달할 것으로 전망

2023년 6억 9,290만 달러로 추정되는 세계 유방 재건 시장은 2023-2030년 동안 연평균 5.6%의 성장률을 보이며 2030년에는 10억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 유방 보형물은 CAGR 7.1%를 기록하여 분석 기간 종료 시점에 6억 2,950만 달러에 도달할 것으로 예상됩니다. 조직 확장기(Tissue Expanders) 부문은 분석 기간 동안 CAGR 4.1%의 성장률을 기록할 것으로 추정됩니다.

미국 시장 1억 8,880만 달러로 추정, 중국은 CAGR 9.4%로 성장 전망

미국의 유방 재건 시장은 2023년 1억 8,880만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023년부터 2030년까지 연평균 9.4%의 성장률을 보이며 2030년에는 2억 1,790만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.1%와 5.7%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.4%의 성장률을 보일 것으로 예상됩니다.

세계 유방 재건 시장 - 주요 동향 및 촉진요인 요약

유방 재건이 암 후 회복에 필수적인 이유는 무엇인가?

유방 재건은 유방암으로 인해 유방 절제술이나 유선종괴 절제술을 받은 여성에게 유방의 모양과 외관을 복원하는 데 필수적인 수술입니다. 많은 사람들에게 유방 재건은 정서적, 심리적 이점을 제공하고 암 치료 후 자기 인식과 신체 이미지를 개선하는 데 도움이 됩니다. 유방암은 전 세계 여성들에게 가장 흔한 암 중 하나이며, 재건 수술에 대한 수요가 증가하고 있습니다. 자가 조직 플랩 및 고품질 임플란트 사용과 같은 수술 기술과 재료의 발전으로 유방 재건 수술은 더 안전하고 효과적이며 개별 환자의 요구에 따라 더 많은 맞춤형 수술이 가능해졌습니다.

기술 혁신은 유방 재건 시술을 어떻게 변화시키고 있는가?

유방 재건의 기술적 발전은 환자의 치료 결과와 시술의 효율성을 크게 향상시켰습니다. 보다 자연스러운 질감과 모양을 포함한 첨단 유방 보형물의 개발은 이 분야에 혁명을 일으켰습니다. 또한, 3D 영상 기술의 사용으로 외과의사는 보다 정밀한 수술 계획을 세우고 환자에게 기대되는 결과를 보다 명확하게 전달할 수 있게 되었습니다. 환자 자신의 지방조직을 사용하여 유방을 재건하는 지방이식술은 기존의 보형물을 대체할 수 있는 보다 자연스러운 방법으로 인기를 끌고 있습니다. 또한 로봇 보조 수술의 통합은 재건 수술의 정확도를 높이고 환자의 회복 시간과 합병증을 줄이고 있습니다.

유방 재건 기기를 관리하는 규제 및 안전 기준은 무엇인가?

규제 기준은 유방 재건 기기, 특히 보형물 및 수술기구의 안전성과 유효성을 보장하는 데 중요한 역할을 합니다. 미국에서는 FDA가 유방 보형물의 승인 및 규제를 감독하고 안전 및 품질 기준을 충족하기 위해 엄격한 임상시험을 의무화하고 있습니다. 유럽에서는 CE 마크가 임플란트가 건강, 안전 및 환경 보호 표준을 충족한다는 것을 증명하는 역할을 합니다. 또한, 임플란트 파열, 피막 수축 또는 유해한 면역 반응과 같은 장기적인 합병증을 모니터링하기 위해 지속적인 모니터링 및 보고 시스템이 시행되고 있습니다. 이러한 규제 프레임워크를 준수하는 것은 제조업체와 의료 서비스 제공자가 신뢰를 유지하고 환자에게 안전한 재건 옵션을 제공하기 위해 필수적입니다.

유방 재건 시장의 성장을 촉진하는 요인은 무엇인가?

유방 재건 시장의 성장은 유방암 발병률 증가, 재건 기술의 발전, 유방 절제술 후 선택에 대한 인식 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 유방암 발견율이 향상되고 생존율이 높아짐에 따라 치료 후 삶의 질을 높이기 위해 재건 수술을 선택하는 여성들이 증가하고 있습니다. 실리콘 보형물 및 지방 이식법 개발과 같은 기술 혁신은 보다 맞춤화되고 자연스러운 결과를 제공하여 환자들의 만족도를 높이고 있습니다. 또한, 재건 수술에 대한 인식과 접근성이 향상되고 유리한 보험 정책과 결합하여 더 많은 여성들이 이러한 옵션을 모색하도록 장려하여 시장 성장에 기여하고 있습니다.

조사 대상 기업 예시(35개사)

• AbbVie, Inc.
• Allergan Aesthetics
• Establishment Labs S.A.
• GC Aesthetics
• GROUPE SEBBIN SAS
• HansBiomed Co., Ltd.
• Ideal Implant Inc.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson Services, Inc.
• KOKEN CO., LTD.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 성장 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 호주
• 인도
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 아르헨티나
• 브라질
• 멕시코
• 기타 라틴아메리카
• 중동
• 이란
• 이스라엘
• 사우디아라비아
• 아랍에미리트
• 기타 중동
• 아프리카

제4장 경쟁

영문목차

Global Breast Reconstruction Market to Reach US$1.0 Billion by 2030

The global market for Breast Reconstruction estimated at US$692.9 Million in the year 2023, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$629.5 Million by the end of the analysis period. Growth in the Tissue Expanders segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$188.8 Million While China is Forecast to Grow at 9.4% CAGR

The Breast Reconstruction market in the U.S. is estimated at US$188.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$217.9 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Breast Reconstruction Market - Key Trends & Drivers Summarized

Why Is Breast Reconstruction Crucial for Post-Cancer Recovery?

Breast reconstruction is a vital surgical procedure for women who have undergone mastectomy or lumpectomy due to breast cancer, helping restore the shape and appearance of the breast. For many, breast reconstruction offers emotional and psychological benefits, contributing to their sense of self and body image after cancer treatment. With breast cancer being one of the most common cancers among women worldwide, the demand for reconstructive surgeries is on the rise. Advancements in surgical techniques and materials, such as the use of autologous tissue flaps and high-quality implants, have made breast reconstruction procedures safer, more effective, and more customizable, catering to individual patient needs.

How Are Technological Innovations Transforming Breast Reconstruction Procedures?

Technological advancements in breast reconstruction are significantly improving patient outcomes and procedural efficiency. The development of advanced breast implants, including those with more natural textures and shapes, has revolutionized the field. In addition, the use of 3D imaging technology allows surgeons to plan surgeries with greater precision, providing patients with a clearer idea of expected results. Fat grafting techniques, which involve using the patient’s own fat tissue to rebuild the breast, are also gaining popularity as a more natural alternative to traditional implants. Furthermore, the integration of robotic-assisted surgery is enhancing the accuracy of reconstruction procedures, reducing recovery times and complications for patients.

What Regulatory and Safety Standards Govern Breast Reconstruction Devices?

Regulatory standards play a crucial role in ensuring the safety and efficacy of breast reconstruction devices, particularly implants and surgical tools. In the U.S., the FDA oversees the approval and regulation of breast implants, requiring rigorous clinical testing to ensure they meet safety and quality standards. In Europe, the CE mark serves as a certification that the implants comply with health, safety, and environmental protection standards. Additionally, ongoing surveillance and reporting systems are in place to monitor long-term complications such as implant rupture, capsular contracture, or adverse immune reactions. Compliance with these regulatory frameworks is essential for manufacturers and healthcare providers to maintain trust and provide patients with safe reconstruction options.

What Factors Are Driving the Growth of the Breast Reconstruction Market?

The growth in the breast reconstruction market is driven by several factors, including the rising incidence of breast cancer, advancements in reconstructive techniques, and increasing awareness of post-mastectomy options. As breast cancer detection rates improve and survival rates increase, more women are opting for reconstruction surgeries to enhance their quality of life post-treatment. Technological innovations, such as the development of silicone implants and fat grafting techniques, are providing more customizable and natural-looking results, increasing patient satisfaction. Additionally, greater awareness and accessibility to reconstructive surgery, combined with favorable insurance policies, are encouraging more women to explore these options, contributing to the market's growth.

Select Competitors (Total 35 Featured) -

• AbbVie, Inc.
• Allergan Aesthetics
• Establishment Labs S.A.
• GC Aesthetics
• GROUPE SEBBIN SAS
• HansBiomed Co., Ltd.
• Ideal Implant Inc.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson Services, Inc.
• KOKEN CO., LTD.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Breast Reconstruction - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Breast Cancer and Rise in Mastectomy Rates Drive Demand for Breast Reconstruction Procedures
  • Advancements in Implant Technology and Materials Propel Adoption of Modern Breast Reconstruction Implants
  • Growing Popularity of Autologous Tissue Reconstruction Techniques Strengthens Market Demand for Advanced Surgical Options
  • Expansion of Oncoplastic Surgery Techniques Creates New Growth Opportunities in Breast Reconstruction Procedures
  • Increasing Focus on Patient-Centered Care Drives Demand for Customized and Natural-Looking Breast Reconstruction Solutions
  • Rising Adoption of 3D Imaging and Surgical Planning Tools Enhances Precision and Outcomes in Breast Reconstruction Procedures
  • Growing Demand for Minimally Invasive Reconstruction Techniques Expands Market Applications in Diverse Patient Populations
  • Emergence of Bioengineered Implants and Regenerative Tissue Technologies Propels Innovation in Breast Reconstruction Solutions
  • Growing Focus on Psychological and Aesthetic Outcomes Strengthens Market for Post-Mastectomy Breast Reconstruction
  • Increasing Role of Robotic-Assisted Techniques in Breast Reconstruction Surgery Drives Technological Advancements
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Breast Reconstruction Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Breast Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Breast Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Breast Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Breast Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Tissue Expanders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Tissue Expanders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Tissue Expanders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Acellular Dermal Matrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Acellular Dermal Matrix by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Acellular Dermal Matrix by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Cosmetology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Cosmetology Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Cosmetology Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• JAPAN
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• CHINA
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: China 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• EUROPE
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Breast Reconstruction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• FRANCE
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: France 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• GERMANY
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Breast Reconstruction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 107: Australia Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Australia Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 109: Australia 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 110: Australia Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Australia Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 112: Australia 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• INDIA
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 113: India Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 114: India Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 115: India 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 116: India Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 117: India Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 118: India 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 119: South Korea Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 120: South Korea Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 121: South Korea 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 123: South Korea Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 124: South Korea 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Rest of Asia-Pacific Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Breast Reconstruction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 133: Latin America 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 136: Latin America 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 139: Latin America 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 140: Argentina Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Argentina Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 142: Argentina 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Argentina Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 145: Argentina 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 146: Brazil Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Brazil Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 148: Brazil 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Brazil Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 151: Brazil 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 152: Mexico Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Mexico Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 154: Mexico 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Mexico Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 157: Mexico 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Rest of Latin America Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 160: Rest of Latin America 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 163: Rest of Latin America 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Breast Reconstruction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 166: Middle East 16-Year Perspective for Breast Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 169: Middle East 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 172: Middle East 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 173: Iran Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 174: Iran Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 175: Iran 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 176: Iran Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 177: Iran Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 178: Iran 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 179: Israel Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Israel Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 181: Israel 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 182: Israel Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Israel Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 184: Israel 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Saudi Arabia Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 187: Saudi Arabia 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 190: Saudi Arabia 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 191: UAE Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 192: UAE Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 193: UAE 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 194: UAE Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 195: UAE Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 196: UAE 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Rest of Middle East Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 199: Rest of Middle East 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 202: Rest of Middle East 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030
• AFRICA
  • Breast Reconstruction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 203: Africa Recent Past, Current & Future Analysis for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Africa Historic Review for Breast Reconstruction by Device Type - Breast Implants, Tissue Expanders and Acellular Dermal Matrix Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 205: Africa 16-Year Perspective for Breast Reconstruction by Device Type - Percentage Breakdown of Value Sales for Breast Implants, Tissue Expanders and Acellular Dermal Matrix for the Years 2014, 2024 & 2030
  • TABLE 206: Africa Recent Past, Current & Future Analysis for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Africa Historic Review for Breast Reconstruction by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 208: Africa 16-Year Perspective for Breast Reconstruction by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Cosmetology Clinics End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION